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Microbe-induced receptor trafficking has emerged
as an essential means to promote innate immune
signal transduction. Upon detection of bacterial lipo-
polysaccharides (LPS), CD14 induces an inflamma-
tory endocytosis pathway that delivers Toll-like re-
ceptor 4 (TLR4) to endosomes. Although several
regulators of CD14-dependent TLR4 endocytosis
have been identified, the cargo-selectionmechanism
during this process remains unknown. We reveal
that, in contrast to classic cytosolic interactions
that promoted the endocytosis of transmembrane
receptors, TLR4 was selected as cargo for inflamma-
tory endocytosis entirely through extracellular in-
teractions. Mechanistically, the extracellular protein
MD-2 bound to and dimerized TLR4 in order to pro-
mote this endocytic event. Our analysis of LPS vari-
ants from human pathogens and gut commensals
revealed a common mechanism by which bacteria
prevent inflammatory endocytosis. We suggest that
evasion of CD14-dependent endocytosis is an attri-
bute that transcends the concept of pathogenesis
and might be a fundamental feature of bacteria that
inhabit eukaryotic hosts.
INTRODUCTION
The pattern recognition receptors (PRRs) of the innate immune
system are a diverse family of structurally unrelated proteins
that are grouped functionally by their ability to detect microbial
products (Akira et al., 2006). Microbial detection initiates signal
transduction pathways that promote the expression of inflam-
matory chemokines, cytokines, and interferons (IFNs). Central
to our understanding of PRR biology is the Toll-like receptor
(TLR) family, which consists of type I transmembrane proteins
that reside at plasma or endosomal membranes, depending on
the family member (Akira et al., 2006). Individual TLRs recognize
conserved microbial products, such as bacterial lipopolysac-Icharides (LPS) and lipoproteins, flagellin subunits, double-
stranded RNA, and others.
Although TLRs are often discussed as receptors for microbial
products, increasing evidence indicates that high-affinity recep-
tor-ligand interactions depend on the actions of ligand-binding
proteins that work together to dimerize TLRs and promote signal
transduction (Lee et al., 2012). For example, LPS-binding protein
(LBP), CD14, MD-2, and TLR4 all form direct contacts with LPS,
and each is necessary to promote the detection of picomolar
LPS concentrations (Gioannini et al., 2004). In the absence of
any of these accessory proteins, the concentrations of LPS
needed to activate inflammation increase by several orders of
magnitude (Gioannini and Weiss, 2007). In recent years, the
idea that accessory proteins facilitate high-affinity receptor-
ligand interactions has been extended to include TLR2, TLR3,
TLR7, and TLR9 (Lee et al., 2012). Based on these discoveries,
it is generally thought that after ligand binding, all subsequent
cellular responses are mediated by the TLR, not the accessory
proteins.
The idea that accessory proteins cannot elicit any cellular re-
sponses independent of a TLR was challenged in recent years
by the discovery that CD14 can induce cellular responses that
TLR4 cannot (Zanoni et al., 2011). This finding derived from our
studies of the subcellular sites of TLR4 signal transduction
(Kagan et al., 2008).
The initiation of TLR4 signal transduction occurs in phos-
phatidylinositol 4,5-bisphosphate (PI(4,5)P2)-rich regions of the
plasma membrane, where a sorting adaptor called TIRAP
resides (Kagan and Medzhitov, 2006). TIRAP senses active
(i.e., dimerized) TLR4 through interactions between the Toll/
IL-1 receptor (TIR) domains present in each of these proteins
(Kagan and Barton, 2015). These TIR-TIR interactions prompt
TIRAP to assemble a higher-order filamentous structure called
the myddosome, which consists of the signaling adaptor
MyD88 and several IRAK family kinases (Bonham et al., 2014;
Lin et al., 2010). The myddosome is a supramolecular organizing
center (SMOC) that initiates signaling events that activate inflam-
matory transcription factors such as AP-1 and NF-kB (Kagan
et al., 2014; Medzhitov and Horng, 2009).
Concomitant with TLR4 signaling is the initiation of events
that promote TLR4 endocytosis. Upon delivery to endo-
somes, TLR4 engages another sorting adaptor, TRAM, andmmunity 43, 909–922, November 17, 2015 ª2015 Elsevier Inc. 909
the signaling adaptor TRIF, which promote the subsequent
expression of IFNs and IFN-stimulated genes (ISGs) (Kagan
et al., 2008). The importance of the endosome-specific
signaling pathway is underscored by the fact that most TLR4-
inducible genes (even those activated by MyD88) are depen-
dent on TRIF (Yamamoto et al., 2003). Thus, in the case of
TLR4, a dominant site of TLR4 signal transduction (endosomes)
is distinct from the site of ligand binding (plasma membrane)
(Kagan and Barton, 2015).
CD14 is a crucial regulator of TLR4 endocytosis and, con-
sequently, of TRIF-dependent signaling from endosomes
(Zanoni et al., 2011). Several cytosolic regulators of CD14-
dependent endocytosis are known, including the tyrosine
kinase Syk, ITAM-containing adaptors, phospholipase C gamma
2 (PLCg2), and various second messenger molecules (Chiang
et al., 2012; Zanoni et al., 2011). These factors might constitute
an inflammatory endocytosis pathway that is triggered by
diverse upstream receptors, such as CD14 and the immune-
related receptors Dectin-1 and FcgR1 (Crowley et al., 1997;
Underhill et al., 2005). The finding that CD14 promotes TLR4
endocytosis is unusual, because this protein is anchored to the
plasma membrane via a C-terminal glycosylphosphatidylinositol
(GPI) anchor. Few other examples exist of GPI-anchored pro-
teins that promote transmembrane receptor endocytosis. How
GPI-anchored proteins promote the endocytosis of transmem-
brane receptors is an under-explored area of biology.
Based on the function of CD14 as an LPS-binding protein, it
is possible that this protein simply transfers LPS to TLR4,
which then enlists either MyD88 or TRIF to promote endocytosis.
However, signaling-deficient TLR4 mutants are fully capable of
undergoing endocytosis, as are macrophages derived from mice
lacking both the MyD88 and TRIF adaptors (Zanoni et al., 2011).
Thus, the endocytosis pathway induced by CD14 does not pro-
ceed via TLR4. These observations reveal that an accessory
protein (CD14) can have more functions than simply delivering li-
gands to TLRs. Rather, this protein acts to transport ligands
(LPS) and receptors (TLR4) to intracellular sites where signaling
canoccur.Despite theseadvances,we lackaclearunderstanding
of themechanisms governing the LPS-inducible transport events.
Herein, we report that the selection of TLR4 as cargo for CD14-
dependent endocytosis proceeded by an unusual mechanism, in
that the cytosolic tail of TLR4 was dispensable for entry into the
cell. We identified the extracellular protein MD-2 as a cargo-se-
lection agent for endocytosis and revealed a common mecha-
nism by which CD14-dependent endocytosis is prevented by
pathogenic and commensal bacteria of the human intestine.
These discoveries establish that CD14 is not the only accessory
protein that has a dual function in ligand transport and receptor
transport: MD-2 also promotes ligand transport to receptor and
receptor transport to endosomes.
RESULTS
CD14Must Bind to LPS Directly to Select TLR4 as Cargo
for Inflammatory Endocytosis
Although CD14 is required to promote inflammatory endocytosis
in response to LPS, themolecular interactions needed to accom-
plish this task are unclear. To determine whether the interaction
between LPS and CD14 was required to initiate the inflammatory910 Immunity 43, 909–922, November 17, 2015 ª2015 Elsevier Inc.endocytosis pathway, we generated a CD14 mutant that could
not bind LPS. Four regulatory regionswithinmurine CD14, desig-
nated as R1 to R4, are involved in LPS recognition (Figure 1A;
Stelter et al., 1997). Mutagenizing one or two of these regions
by alanine replacement (designated as mutants 1R and 2R; Fig-
ure 1B) resulted in a modest defect in the binding between
CD14 and biotinylated LPS in vitro. Only when all four regions
weresubstitutedwithalanine (mutant4R)didweobserveasevere
LPSbinding defect (Figure 1B). This 4Rmutant could therefore be
used as a tool to study the importance of LPS binding by CD14.
To determine whether defects in LPS binding in vitro resulted
in defects in endocytosis within cells, wild-type (WT) and mutant
CD14 alleles were introduced into Cd14/ immortal bone
marrow-derived macrophages (iBMDM) by retroviral transduc-
tion. Fluorescence activated cell sorting (FACS) was used to
isolate homogenous cell populations that exhibited comparable
surface CD14 staining (Figure 1C). The resulting cells were
examined for their ability to promote CD14 and TLR4 endocy-
tosis in response to LPS. Endocytosis assays were performed
via a highly sensitive and quantitative flow cytometry-based
assay that tracks the endogenous receptors as they are internal-
ized from the plasma membrane into endosomes (Akashi et al.,
2003; Kagan et al., 2008; Zanoni et al., 2011).
Upon LPS stimulation, rapid CD14 endocytosis was observed
in cells expressing WT CD14 and the CD14 1R mutant, whereas
the 2R mutant exhibited a delayed rate of CD14 internalization
(Figure 1D). The CD14 4R, which is most defective for LPS bind-
ing activity in vitro, was unable to be internalized into cells in the
presence of LPS (Figure 1D). These data indicate that LPS bind-
ing by CD14 is necessary for endocytosis.
We observed a similar requirement for LPS binding by CD14 to
promote TLR4 endocytosis, with only the LPS-binding-deficient
CD14 mutant being defective for TLR4 endocytosis (Figure 1E).
These data establish that a physical interaction between CD14
and LPS is required to select TLR4 as cargo for inflammatory
endocytosis.
CD14 Is on a Constitutive Endocytosis Pathway that Is
Accelerated by LPS
Extensive kinetic analysis of LPS-induced CD14 endocytosis re-
vealed that this process is rapid: 80% of the CD14 was internal-
ized into iBMDMs within 2 min of LPS treatment (Figure S1A).
The internalization of TLR4 occurred within the same time frame
(Figure S1B). Further monitoring of surface CD14 revealed the
re-appearance of CD14 at the plasma membrane at late time
points (120 min) (Figure 1D). In contrast, TLR4 never reappeared
at the plasma membrane after endocytosis (Figure 1E). One
possiblemechanism of CD14 re-appearance is through the recy-
cling of receptors to the cell surface after endocytosis, whereas
another possibility is that newly synthesized CD14 re-populates
the plasma membrane. These possibilities can be distinguished
through the use of translation inhibitors, which should block new
CD14 synthesis but not affect recycling of previously internalized
receptors.
WT iBMDMs were treated with the translation inhibitor
cycloheximide in the presence or absence of LPS, and the endo-
cytosis of CD14 and TLR4wasmonitored. LPS treatment caused
the rapid endocytosis of CD14, followed by re-appearance of this
receptor 120 min after stimulation (Figure 2A). In contrast, LPS
Figure 1. CD14 Must Bind LPS to Promote
TLR4 Endocytosis
(A) Schematic of the CD14 LPS binding region. Key
regulatory motifs involved in LPS binding are
highlighted. The amino acids indicated were all
mutated to alanine to create the mutant alleles 1R,
2R, or 4R, which are used in this figure.
(B) Lysates of 293T cells expressing the indicated
CD14 mutants were incubated with biotinylated
LPS (5 mg). The CD14-LPS complex were then
captured with neutraviden beads. The amount of
indicated CD14 mutants retained by LPS was
determined by immunoblotting.
(C) Surface level of different CD14 alleles ex-
pressed in Cd14/ iBMDMs was determined by
flow cytometry.
(D) Cells of the indicated genotypes were treated
with LPS (1 mg/ml) for the times indicated. CD14
surface staining was measured by flow cytometry.
Line graphs represent mean florescence intensity
(MFI) of CD14 over the time course.
(E) Cells of the indicated genotypes were treated
with LPS (1 mg/ml) for the times indicated. Surface
level of TLR4 was measured by flow cytometry.
Line graphs represent MFI of TLR4 (right) over the
assay time course.
See also Figure S1.and cycloheximide co-administration abrogated the re-appear-
ance of CD14 at the plasmamembrane but did not prevent endo-
cytosis (Figure 2A).
Treatment of cells with cycloheximide in the absence of LPS
revealed that CD14 is not immobile at the plasma membrane
but rather is undergoing a slow rate of constitutive endocytosis
(Figure 2A). The constitutive rate of CD14 internalization revealed
by cycloheximide was more prominent in primary cells than that
observed in iBMDMs (Figure 2B). This observation is consistent
with the fact that non-dividing (i.e., primary) macrophages
possess higher intrinsic endocytosis activities than do macro-
phages undergoing mitosis (i.e., iBMDMs) (Berlin et al., 1978;
Bonham et al., 2014). Similar results were obtained with another
translation inhibitor, puromycin, where constitutive CD14 endo-
cytosis was observed in primary BMDMs treated with this drug
(Figure 2C). In contrast to the constitutive endocytosis of
CD14, surface staining of TLR4 or the GPI-anchored protein
CD48 did not change when protein synthesis was inhibited in
iBMDMs or primary BMDMs (Figures 2A–2C). These data indi-
cate that CD14 resides specifically within a constitutive endocy-
tosis pathway and that new protein synthesis is required to
replenish the plasma membrane with CD14. This cycling of
CD14 through the cell would explain why constitutive CD14
endocytosis is revealed only by inhibition of translation.
Becausesurface levels ofCD14 in untreatedcells are stable, the
rate of CD14 endocytosis and re-synthesis must be tightly
controlled in order tomaintain surface expression of this receptor.
Because CD14 endocytosis is accelerated by LPS, the rate of re-Immunity 43, 909–922, Nsynthesis must also be accelerated to
accommodate for the greater loss of cell
surface CD14. We therefore predicted
that blocking NF-kB activation should
offset the balance between CD14 endocy-tosis and re-synthesis and should result in the loss of surface ex-
pression of this protein. NF-kB activation was prevented through
the use of Myd88/Ticam-1/ iBMDMs or treatment of WT
iBMDMs with the NF-kB inhibitor Bay11-7085. Both strategies
of NF-kB inhibition prevented the re-appearance of surface
CD14 120 min after LPS treatment (Figure 2D). As expected (Za-
noni et al., 2011), TLR4 endocytosis proceeded normally in
Myd88/Ticam-1/ iBMDMs (Figure 2E). Consistent with the
idea that upregulation ofCD14 is responsible for the re-population
of this receptor at the plasma membrane, we found that CD14
mRNA was increased upon LPS stimulation (Figure S2B), as
was the inflammatory cytokine Il1b (Figure S2A). Neither Cd14
nor Il1b were expressed upon LPS stimulation of Myd88/
Ticam-1/iBMDMs (Figures S2A and S2B). A perfect correlation
therefore exists between CD14 upregulation and the re-appear-
ance of CD14 at the plasma membrane after LPS treatment.
LPS therefore accelerates the rate of Cd14 expression in order
to compensate for an accelerated rate of CD14 endocytosis.
To explain why CD14 must be re-synthesized to repopulate
the plasma membrane after endocytosis, we considered that
internalized CD14 is degraded in lysosomes. To address this
possibility, the abundance of CD14 in cell lysates was exam-
ined. Consistent with our flow cytometry-based analysis,
CD14 protein abundance remained constant in the steady
state (Figure 2F). In contrast, LPS treatment in the presence
of cycloheximide led to the time-dependent decrease of
CD14 abundance (Figure 2G). Chloroquine treatment, which
blocks lysosomal proteolysis, resulted in the accumulation ofovember 17, 2015 ª2015 Elsevier Inc. 911
Figure 2. Constitutive Endocytosis Is Accelerated by LPS
(A and B) WT iBMDMs (A) and primary BMDMs (B) were treated with LPS (1 mg/ml), cycloheximide (50 mg/ml), and LPS plus cyloheximide, as indicated. Surface
level of CD14 (left) and TLR4 (right) was determined by flow cytometry.
(C) Primary BMDMs were treated with LPS (1 mg/ml) and cycloheximide and puromycin (25 mg/ml) for the indicated times. Surface staining of CD14 (left), CD48
(middle), and TLR4 (right) was determined by flow cytometry.
(D) iBMDMs indicated were incubated with Bay11-7085 (5 mM) or not for 15min, then treated with LPS (1 mg/ml) for the indicated times. Surface level of CD14 was
determined by flow cytometry.
(legend continued on next page)
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Figure 3. The Cytosolic Tail of TLR4 Is Not
Required for Endocytosis
(A) Schematic of three TLR4 alleles. Amino acid
designations, relative to the start codon (position 1)
are indicated. Abbreviations are as follows: ecto,
extracellular domain; TM, transmembrane domain;
cyto, cytosolic tail; CD4, extracellular domain
of CD4.
(B) Cells were treated with LPS or P3C for the
indicated times and lysed. MyD88 was immuno-
precipitated (IP) from lysates and IRAK2 and IRAK4
were detected by immunoblot.
(C) Indicated iBMDM lines were treated with LPS
(100 ng/ml) or PAM3 (100 ng/ml) for 4 hr. il1b and
rsad2 expression were measured by qPCR.
(D) The iBMDMs indicated were treated with LPS
(1 mg/ml) for 30 min. Surface staining of TLR4 was
measured by flow cytometry.
(E) The iBMDMs indicated were treated with LPS
(1 mg/ml) for the times indicated. Surface staining
of TLR4 was measured by flow cytometry. Line
graphs represent the MFI of TLR4 surface staining
at each time point, as compared to the staining
pre-stimulation.
(F) The iBMDMs indicated were treated with LPS
(1 mg/ml) for the times indicated. Surface staining
of CD4 was measured by flow cytometry. Line
graphs represent the MFI of CD4 surface staining
at each time point, as compared to the staining
pre-stimulation.
Error bars represent mean ± SEM from triplicate
readings in one experiment. **p < 0.01; ns, not
significant. See also Figure S3.CD14 after LPS stimulation (Figure 2G). Chloroquine did not
alter the LPS-induced degradation of the kinase IRAK1 (Fig-
ure 2G), which is mediated by the proteasome (Yamin and
Miller, 1997). These results explain the need for CD14 re-
synthesis, because the endocytosed pool of this protein is
degraded in lysosomes.
Collectively, these data reveal that CD14 is present within a
constitutive endocytosis pathway that is accelerated by LPS.
The process of LPS-induced endocytosis acceleration results
in the selection of TLR4 as cargo for entry into the cell, which
effectively converts this immunologically silent entry pathway
into a pathway of inflammatory endocytosis.(E) WT and myd88/ticam1/ iBMDMs were treated with LPS at indicated time points. Surface level of TL
(F) iBMDMs were left untreated or treated with cycloheximide (50 mg/ml) for the indicated times. Cells w
immunoblot. Densitometry analysis of the protein bands was performed with Image J (lower panel).
(G) iBMDMs were treated with cycloheximide (50 mg/ml) or chloroquine (100 mM) plus LPS for indicated time p
were detected by immunoblot. Densitometry analysis of the protein bands was performed with Image J (low
See also Figure S2.
Immunity 43, 909–922, NThe Cytosolic Tail of TLR4 Is Not
Necessary for LPS-Induced
Endocytosis
The observation that CD14 is present on
a constitutive endocytosis pathway that is
accelerated by LPS has implications for
themechanismsbywhichTLR4 is selected
as cargo for entry into the cell. Typically,transmembrane receptors initiate the process of endocytosis de
novo by recruiting proteins to their cytosolic tails to promote their
own internalization (Mellman, 1996). The fact that CD14 endocy-
tosis occurs in resting cells suggests that the tail of TLR4 is not
necessary to initiate entry events, but whether the tail of TLR4 is
necessary for its own selection as cargo is unclear.
To determine whether the TLR4 tail promotes endocytosis, we
constructed two TLR4 alleles (Figure 3A). The first is an allele
called TLR4-delta Tail, which lacks the entire cytosolic tail but
contains the extracellular domain and most of the transmem-
brane domain (Figure 3A). For the second allele (CD4-TLR4
Cyto), the TLR4 extracellular domain was replaced with theR4 was determined by flow cytometry.
ere lysed and CD14 and actin were detected by
oints. Cells were lysed and CD14, IRAK1, and actin
er panel).
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ecto-domain of CD4, leaving the TLR4 transmembrane domain
and the cytosolic tail intact (Figure 3A). Because macrophages
do not express CD4, it serves as a marker to monitor expression
of this chimeric protein. These alleles were retrovirally trans-
duced into Tlr4/ iBMDMs and FACS-based isolation resulted
in stable lines that permitted analysis of the domains necessary
to select cargo for endocytosis. The surface expression of the
TLR4 and CD4 alleles in the respective stable lines was verified
by flow cytometry (Figures S3A and S3B). Importantly, TLR4 sur-
face staining in TLR4-delta Tail-expressing cells was compara-
ble to that of endogenous TLR4 in WT iBMDMs (Figure S3A).
To verify the expected signaling defects of the TLR4 alleles, we
usedmyddosome formation and Il1b expression as read-outs for
signaling from the plasma membrane and the expression of the
ISG Rsad2 (Chin and Cresswell, 2001) to indicate signaling
from endosomes. LPS was unable to induce myddosome as-
sembly or Il1b or Rsad2 expression in cells expressing the
TLR4-delta Tail allele (Figures 3B and 3C). This observation
was expected because this allele lacks the TIR domain. In
contrast, the TLR2 ligand Pam3CSK4 (PAM3) induced myddo-
some formation and Il1b expression, thus demonstrating a spe-
cific defect of TLR4-delta Tail-expressing cells in responding to
LPS (Figures 3B and 3C).
Whereas the delta Tail allele of TLR4 was completely defective
for signaling, this allele retained the ability to be internalized in
response to LPS. Indeed, LPS treatment resulted in the time-
dependent loss of TLR4-delta Tail surface staining, albeit slightly
less efficiently than that observed in WT iBMDMs (Figures 3D
and 3E). In contrast, no endocytosis of CD4 was observed in
the CD4-TLR4 Cyto-expressing iBMDMs (Figure 3F). The effi-
ciency of CD14 internalization in each cell population was similar
to that observed in WT iBMDMs (Figures S3C and S3D). These
data establish that the TLR4 cytosolic tail is neither necessary
nor sufficient for its own endocytosis. Thus, unlike traditionally
discussed mechanisms by which transmembrane receptors
use their cytosolic tails to promote internalization, extracellular
interactions probably promote the selection of TLR4 as cargo
for CD14-dependent endocytosis.
The Extracellular Protein MD-2 Is the Cargo-Selection
Agent for TLR4 Endocytosis
The observation that the TLR4 ecto- and transmembrane do-
mains are sufficient to support TLR4 endocytosis suggests
that extracellular interactions are important for this process.
The LPS-binding protein MD-2 was a candidate regulator of
TLR4 cargo selection, because this protein interacts directly
with the TLR4 ecto-domain (Shimazu et al., 1999). However,
the only known function of MD-2 is to deliver LPS to TLR4, not
to transport TLR4. To characterize the role of MD-2 in TLR4
endocytosis, we generated MD-2-deficient iBMDMs from the
marrow of mice lacking Ly96. Consistent with prior observations
using primary cells (Nagai et al., 2002), Ly96/ iBMDMs are
non-responsive to LPS, as we observed neither myddosome for-
mation nor expression of Il1b or Rsad2 in the absence of MD-2
(Figures 4A and 4B). The defects in LPS signaling could be com-
plemented by retroviral expression of an HA-tagged MD-2 in
Ly96/ iBMDMs (Figures 4A and 4B).
To examine the contribution of MD-2 to LPS-induced endocy-
tosis, we monitored TLR4 endocytosis in Ly96/ BMDMs. The914 Immunity 43, 909–922, November 17, 2015 ª2015 Elsevier Inc.absence of MD-2 completely abolished the internalization of
TLR4 upon LPS treatment of immortal or primary Ly96/
BMDMs (Figures 4C and 4D). Expression of MD-2 in Ly96/
iBMDMs restored TLR4 endocytosis (Figure 4C). Remarkably,
unlike all other known regulators of TLR4 endocytosis, which
are required for both CD14 and TLR4 internalization, MD-2 was
not necessary for CD14 endocytosis in either primary or immortal
BMDMs (Figures 4C and 4D). These collective data reveal that,
likeCD14,MD-2 hasmore functions than just transportingmicro-
bial ligands; this protein also transports receptors into the cell.
TheMechanismsGoverning TLR4CargoSelectionApply
to All Means of LPS Endocytosis
LPS can exist within soluble micelles or in association with bac-
teria, andmight enter cells through several pathways, depending
on its formulation. The mechanisms of CD14 endocytosis might
also be diverse, as indicated by the fact that cells defective for
galectin-3, a protein that controls the internalization of several
GPI-anchored proteins (Lakshminarayan et al., 2014), were not
defective for CD14 or TLR4 endocytosis (Figure S5). We sought
to determine whether alterations in the cargo property (intact
bacteria versus soluble LPS) or the route of entry (phagocytosis
versus endocytosis) could influence the mechanisms of TLR4
endocytosis. iBMDMs were treated with E. coli that had been
opsonized with IgG (or not) and monitored for CD14 and TLR4
endocytosis. Confocal microscopy revealed a substantial in-
crease in uptake of opsonized E. coli into all iBMDM genotypes
(WT, Cd14/, and Ly96/) in comparison to their unopsonized
counterparts (Figure S4A), as expected. Interestingly, the re-
quirements of CD14 and MD-2 for TLR4 endocytosis could not
be bypassed by altering the physical properties of cargo, as
Cd14/ and Ly96/ iBMDMs were unable to internalize TLR4
under any condition examined (Figures S4B and S4C). CD14
internalization proceeded normally in all cells (Figure S4C).
Thus, despite the fact that multiple entry routes for LPS (and
perhaps CD14) exist, the means by which TLR4 is selected as
cargo for endocytosis in macrophages is universal and always
requires CD14 and MD-2.
Dimerization of TLR4 by MD-2 Coordinates TLR4
Signaling and Endocytosis
MD-2 promotes TLR4 dimerization at the plasma membrane
(Saitoh et al., 2004), a process necessary to initiate TLR4
signaling. CD14-dependent endocytosis is not promoted by
TLR4 signaling, so it was unclear whether the ability of MD-2
to dimerize TLR4 would contribute to endocytosis. We per-
formed mutational analysis of MD-2 to identify the mechanism
by which this protein selects TLR4 as cargo for endocytosis.
We focused on two MD-2 mutants. The first mutant is MD-2
C95A, which abolishes MD-2 and TLR4 interactions (Schromm
et al., 2001). The second mutant is MD-2 F126A, which does
not affect TLR4 binding but impairs the LPS-induced dimeriza-
tion of different TLR4/MD-2 complexes at the plasmamembrane
(Figure 5A; Kawasaki et al., 2003; Schromm et al., 2001). The
behavior of these mutant MD-2 alleles (with a C-terminal HA
epitope tag) was first verified biochemically in 293T cells.
Compared to WT MD-2 and MD-2 F126A, TLR4 formed a
weak complex with MD-2 C95A, as assessed by co-immuno-
precipitation after production of each protein in 293T cells
Figure 4. MD-2 Selects TLR4 as Cargo for
LPS-Induced Endocytosis
(A) The iBMDMs indicated were treated with LPS
for the times indicated. Myddosome formation was
then examined as described in Figure 3B.
(B) The iBMDMs indicated were treatedwith LPS at
10 ng/ml or 100 ng/ml for 4 hr. il1b and rsad2
expression was then determined by qPCR.
(C and D) iBMDMs (C) or primary BMDMs (D)
indicated were treated with LPS (1 mg/ml) for the
indicated times. Surface staining of CD14 and
TLR4 was determined by flow cytometry. Line
graphs represent the MFI of TLR4 and CD14 sur-
face staining at given time points from each cell
line.
Error bars represent mean ± SEM from triplicate
readings in one experiment. **p < 0.01; ns, not
significant. See also Figure S5.(Figure S6A). The specificity of this interaction was verified
through the use of the TLR4 allele in which the ecto-domain
was replaced with that of CD4. This allele of TLR4 could not
form a complex with MD-2 (Figure S6A).
A functional flow cytometry-based assay was also used to
determine the association of these MD-2 alleles with TLR4 in
living iBMDMs. We reasoned that because MD-2 is a secreted
protein that binds the TLR4 ecto-domain, then the MD-2 mutant
defective in TLR4 binding would be secreted directly into the cell
culture medium, thereby resulting in negative surface HA stain-
ing. In contrast, MD-2 alleles that bind TLR4 should result in
HA-positive cells. HA-tagged MD-2 alleles were introduced
into Ly96/ iBMDMs, and surface HA staining was examined
by flow cytometry. Our prediction was correct: Ly96/ iBMDMs
transduced with WT MD-2 and MD-2 F126 displayed positive
surface HA staining (Figure S6B). In contrast, no surface HA
staining could be detected from the MD-2 C95A-expressingImmunity 43, 909–922, Ncells (Figure S6B). Expression of WT
MD-2 in tlr4/ iBMDMs did not result
in any surface HA staining (Figure S6B).
Importantly, all the MD-2 mutants re-
tained their LPS-binding capacity (Fig-
ure S6B). These MD-2 mutants were
therefore used as tools to assess
their influence on TLR4 signaling and
endocytosis.
iBMDMs expressing various MD-2 mu-
tants were treated with LPS, and myddo-
some formation, gene expression, and
endocytosis were assessed. Cells ex-
pressing WT MD-2 fully restored TLR4-
dependent myddosome formation and
Il1b and Rsad2 expression (Figures 5B–
5D). In contrast, Ly96/ iBMDMs ex-
pressing MD-2 C95A or F126A remained
poorly responsive to LPS, as did the cells
expressing an empty retroviral vector
(Figures 5B–5D).
TLR4 endocytosis and TLR4/MD-2
dimerization was then assessed. WhereasTLR4 endocytosis was examined with the Sa15-21 antibody
used throughout this study, TLR4 dimerization was assessed
with the MTS510 antibody, which detects only TLR4 monomers
(Akashi et al., 2000). Because this antibody recognizes mono-
meric TLR4/MD2 at the plasma membrane, loss of surface
staining of MTS510 represents receptor dimerization (or clus-
tering) induced by LPS (Akashi et al., 2000). Consistent with this
idea, LPS induced the rapid dimerization of TLR4 at the plasma
membrane in cells expressing WT MD-2 (Figure 5E). No change
in dimerization was observed in cells expressing the MD-2
C95A mutant that cannot bind TLR4 or in cells harboring the
empty vector (Figure 5E). Cells expressing MD-2 F126A dis-
played a modest increase in TLR4 dimers in the presence of
LPS (Figure 5E). These results are consistent with residue F126
being required to efficiently dimerize TLR4. Remarkably, the
exact same trend of cellular behaviors was observed when the
LPS-induced endocytosis of TLR4 was examined. TLR4 wasovember 17, 2015 ª2015 Elsevier Inc. 915
Figure 5. Dimerization of TLR4 by MD-2 Co-
ordinates TLR4 Signaling and Endocytosis
(A) Schematic of MD-2 mutants used in the study.
The C95A mutation abolishes the binding between
MD-2 and TLR4. The F126A mutation prevents
efficient dimerization of TLR4/MD-2 complexes.
(B) iBMDMs indicated were stimulated with LPS
and myddosomes were isolated from cell lysates
at the times indicated.
(C and D) iBMDMs indicated were stimulated with
LPS (100 ng/ml) for 4 hr, and il1b and rsad2mRNA
expression was examined by qPCR.
(E) iBMDMs indicated were stimulated with LPS for
times indicated. TLR4/MD-2 dimerization (left),
TLR4 endocytosis (middle), and CD14 endocytosis
(right) were determined by flow cytometry.
Error bars represent mean ± SEM from triplicate
readings in one experiment. *p < 0.05, **p < 0.01;
ns, not significant. See also Figure S6.internalized rapidly into cells expressing WT MD-2, whereas
no TLR4 endocytosis was observed in cells carrying the
empty vector or expressing MD-2 C95A (Figure 5E). Cells ex-
pressing the dimerization-deficient F126A mutant exhibited a
substantial defect in TLR4 endocytosis (Figure 5E). Indeed, at
30 min after LPS treatment, cells expressing this allele were
as defective as Ly96/ cells at inducing TLR4 endocytosis.
None of the MD-2 mutants alter the efficiency of CD14 endo-
cytosis (Figure 5E). Collectively, these data reveal that, in
addition to promoting transcriptional responses, TLR4 dimeriza-
tion by MD-2 promotes the selection of TLR4 as cargo for
endocytosis.
A Therapeutic LPS Variant Prevents the Selection of
TLR4 as Cargo for Inflammatory Endocytosis
LPS variants that contain fewer than six acyl chains are weak in-
ducers of TLR4 dimerization (Tan and Kagan, 2014) and might
therefore be less capable of promoting TLR endocytosis. To
address this possibility, we compared penta-acylated LPS
from Rhodobacter sphaeroides (Rs-LPS) (Strittmatter et al.,
1983; Visintin et al., 2005) to its hexa-acylated counterpart
from E. coli (Ec-LPS). Ec-LPS triggered robust myddosome for-
mation, Il1b and Rsad2 expression, whereas Rs-LPS did not
elicit any of these responses (Figures 6A and 6B). Rs-LPS was
also capable of only modest dimerization of TLR4, as compared916 Immunity 43, 909–922, November 17, 2015 ª2015 Elsevier Inc.to Ec-LPS (Figure 6C). Consequently,
TLR4 endocytosis proceeded very ineffi-
ciently in cells treated with Rs-LPS (Fig-
ure 6C). These data are consistent with
the idea that dimerization of TLR4 is
necessary for its selection as endocytosis
cargo (Figure 5E). Interestingly, despite its
defective ability to crosslink or activate
TLR4, Rs-LPS accelerated CD14 endocy-
tosis as efficiently as Ec-LPS (Figure 6C),
indicating that CD14 does not discrimi-
nate between Rs-LPS and Ec-LPS
(Delude et al., 1995). These results there-
fore reveal that CD14 and TLR4 endocy-tosis can be uncoupled in WT cells, which creates an inducible
CD14 deficiency at the plasma membrane.
The ability of Rs-LPS to create a CD14 deficiency at the
plasmamembrane would be expected to render this LPS variant
a TLR4 antagonist. Indeed, Rs-LPS is well known to have inhib-
itory actions toward TLR4 (Mullarkey et al., 2003). We reasoned
that if the CD14 deficiency induced by Rs-LPS is functionally
important, then TLR4 responses most dependent on CD14
should be most inhibited by Rs-LPS. Of the known TLR4-depen-
dent transcriptional responses, TRIF-dependent gene expres-
sion is more sensitive to the loss of CD14 than MyD88-depen-
dent gene expression (Perera et al., 1997). Consistent with
this idea, co-administration of Ec-LPS and Rs-LPS resulted in
a near complete loss of TRIF-dependent Rsad2 expression,
whereas MyD88-dependent Il1b expression was only modestly
affected (Figure 6D). This strong defect in TRIF-dependent
signaling correlated with a defect in TLR4 endocytosis (Fig-
ure 6E). Interestingly, whereas Rs-LPS antagonized TLR4
endocytosis induced by Ec-LPS, co-administration of these
LPS variants potentiated CD14 endocytosis (Figure 6E). This
observation supports the idea that CD14 does not differentiate
Ec-LPS and Rs-LPS. Rs-LPS also prevented myddosome for-
mation, but not to an extent that MyD88 signaling was ablated
(Figures 6D and 6F). Thus, uncoupling of CD14 and TLR4 endo-
cytosis can occur in WT cells and results in a functional CD14
Figure 6. An LPS Variant Dissociates CD14 and TLR4 Endocytosis
(A) iBMDMs were stimulated with E. coli LPS (Ec-LPS, 100 ng/ml) and R. sphaeroides LPS (Rs-LPS, 100 ng/ml) for indicated times. The assembly of myddosome
was then examined by immunoblot.
(B) iBMDMs were treated with Ec-LPS (100 ng/ml) or Rs-LPS (100 ng/ml) for 4 hr, il1b and rsad2 expression were measured by qPCR.
(C) iBMDMs were stimulated with LPS for times indicated. TLR4/MD-2 dimerization (left), TLR4 endocytosis (middle), and CD14 endocytosis (right) were
determined by flow cytometry.
(D–F) iBMDMs were stimulated with Ec-LPS (100 ng/ml) and mixtures of Ec-LPS and Rs-LPS at the ratio of 1:5 or 1:10 (100 ng/ml Ec-LPS plus 500 ng/ml Rs-LPS
or 100 ng/ml Ec-LPS plus 1,000 ng/ml Rs-LPS) for 4 hr. il1b and rsad2 expression was then measured by qPCR.
(E and F) Similar treatments as (D), except surface TLR4 (left) and CD14 (right) staining was determined by flow cytometry, or myddosome assembly was
examined.
Error bars represent mean ± SEM from triplicate readings in one experiment. **p < 0.01.
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deficiency that results in severe defects in TLR4-TRIF signal
transduction.
A Common Strategy Is Used by Pathogenic and
Commensal Bacteria of the Human Intestine to Evade
CD14-Dependent Inflammatory Endocytosis
R. sphaeroides does not naturally interact with a mammalian
host. We therefore sought to examine the role of LPS variation
in bacteria that naturally colonize mammals. We first chose
LPS from Francisella tularensis, because of its low immuno-stim-
ulatory effect (Gunn and Ernst, 2007). Key to the immune-
evasion features of F. tularensis LPS (Ft-LPS) is themodifications
on Lipid A, which renders it hypo-phosphorylated, hypo-acyl-
ated, and possessing longer acyl chains in comparison to the
Ec-LPS (Vinogradov et al., 2002). We treated WT iBMDMs with
Ec-LPS and Ft-LPS. As compared to Ec-LPS treatment, which
induced myddosome formation and Il1b and Rsad2 expression,
Ft-LPS did not induce these responses (Figures 7A and 7B).
Because of the under-acylated nature of Ft-LPS, we expected
that Ft-LPS would behave similarly to Rs-LPS and promote the
endocytosis of CD14, but not TLR4. However, we found that
Ft-LPS did not induce the internalization of CD14 or TLR4 (Fig-
ure 7C). Moreover, Ft-LPS was unable to induce any detectable
dimerization of TLR4/MD-2 (Figure 7C). Thus, unlike Rs-LPS, Ft-
LPS does not uncouple CD14 and TLR4 endocytosis, but rather
evades detection by CD14 entirely.
To determine whether the ability to evade CD14 was a feature
common to other bacteria that colonize mammals, we con-
sidered commensal bacteria of the human intestine. Like
bacterial pathogens, commensal bacteria have co-evolved
with the host immune system. Bacteroides, the most prominent
genus in the distal human intestine, produce LPS with penta-
acylated and monophosphorylated Lipid A (Xu et al., 2003).
Bacteroides encode the LpxF phosphatase, which is respon-
sible for producing monophosphorylated Lipid A (Cullen et al.,
2015). To determine whether the phosphorylation state of
B. thetaiotaomicron LPS (Bt-LPS) influences detection by
CD14 and TLR4/MD-2, we treated iBMDMs with LPS purified
from three B. thetaiotaomicron strains (the wild-type strain, an
lpxFmutant, and a complemented strain). Monophosphorylated
Bt-LPS induced delayed and weak myddosome formation (Fig-
ure 7D) and weak Il1b and Rsad2 expression, as compared to
Ec-LPS (Figure 7E). Interestingly, addition of a single phosphate
group to Bt-LPS, through the use of the lpxF mutant, was suffi-
cient to promote myddosome assembly and high levels of Il1b
and Rsad2 expression, as compared to WT Bt-LPS (Figures
7D and 7E). Importantly, all the phenotypes associated with
Bt-lpxF-LPS were reversed when using LPS derived from the
complemented strain of bacteria (Bt-clpxF-LPS), thus indicating
that the phosphorylation state of Bt-LPS is responsible for
evasion of myddosome formation and gene expression.
Finally, we determined the effect of Bt-LPS on receptor traf-
ficking. Interestingly, monophosphorylated Bt-LPS was less
able to promote CD14 endocytosis than its diphosphorylated
counterparts. Indeed, diphosphorylated Bt-LPS induced CD14
endocytosis to an extent comparable to that induced by Ec-
LPS (Figure 7F). The ability to evade CD14 would be predicted
to allow monophosphorylated Bt-LPS to evade all downstream
events, such as TLR4 dimerization and endocytosis. This predic-918 Immunity 43, 909–922, November 17, 2015 ª2015 Elsevier Inc.tion was correct: monophosphorylated Bt-LPS triggered less-
efficient TLR4/MD-2 dimerization and TLR4 endocytosis, as
compared to their diphosphorylated counterparts or Ec-LPS
(Figure 7F). These collective data reveal a common feature of
commensal and pathogenic LPS: both can evade CD14 endocy-
tosis, perhaps by generating monophosphorylated LPS. The
ability to evade CD14-dependent activities might therefore
represent a common feature of bacteria that inhabit mammalian
hosts.
DISCUSSION
Emerging evidence indicates that ligand-induced TLR trafficking
events can promote specific innate immune responses. The dis-
covery of a requirement for TLR4 endocytosis to induce TRIF-
dependent gene expression exemplifies the importance of these
newly defined microbe-inducible transport events. Although
CD14 represents the first specific regulator controlling the trans-
port of TLR4 to endosomes, the mechanism of how TLR4 is
selected as endocytosis cargo is unknown. Our discovery that
MD-2 is the cargo-selection agent for TLR4 endocytosis re-
vealed a mechanism by which extracellular interactions play a
determinant role in the entry process into a cell. This mechanism
is highly unusual, because most other transmembrane proteins
direct themselves into endosomes through interactions between
their cytosolic tail and various endocytosis regulators (McMahon
and Boucrot, 2011). In contrast, TLR4 alleles that contain no
cytosolic tail retain the ability to be internalized by LPS treatment.
We do note, however, that although the TLR4 tail is not neces-
sary for endocytosis, our findings do not negate a role for the
tail in post-endocytosis sorting of TLR4 into the lumen of multi-
vesicular bodies (Chuang and Ulevitch, 2004; Husebye et al.,
2006), which is critical for signaling downregulation.
Our analysis of the mechanism by which MD-2 promotes
endocytosis revealed that direct interactions with TLR4 are not
sufficient. Rather, MD-2 must dimerize TLR4 before endocytosis
can be achieved. This conclusion is supported by our analysis of
both MD-2 mutants that are defective for TLR4 crosslinking ac-
tivity and analysis of hypo-acylated LPS variants that cannot effi-
ciently crosslink TLR4. This finding is notable, because TLR4
dimerization has most often been considered a mechanism of
promoting TLR4 signal transduction. The fact that endocytosis
is not mediated by TLR4 signaling indicates that TLR4 crosslink-
ing byMD-2 is an activity that coordinates the signaling functions
of TLR4 with the endocytosis functions of CD14. Of note, in
BMDMs, the cargo-selection function of MD-2 for TLR4 endocy-
tosis could not be circumvented by altering the means of uptake
(e.g., Fc receptor-mediated phagocytosis). These results sup-
port a model whereby CD14 is constantly cycling through the
plasma membrane, surveying the extracellular environment for
most variants of LPS. Upon binding to hexa-acylated LPS,
CD14 transfers LPS toMD-2, which then dimerizes TLR4. Dimer-
ized TLR4 induces myddosome assembly and signaling at the
plasmamembrane and converts the immunologically silent entry
route taken by CD14 into an inflammatory endocytosis pathway.
Although host transcriptional responses are established to be
influenced by LPS variation, limited information exists of how
LPS variation affects receptor-proximal events. Our observa-
tions with LPS variants from the therapeutically interesting
Figure 7. LPS from Pathogenic and Commensal Bacteria Evade Detection by CD14 and TLR4
(A) iBMDMs were treated with Ec-LPS or Ft-LPS (1 mg/ml) for the indicated times, and the assembly of myddosome was examined as described in Figure 3B.
(B) iBMDMs were treated with Ec-LPS (100 ng/ml) or Ft-LPS (100 ng/ml) for 4 hr, and the expression of il1b (left) and rsad2 (right) was measured by qPCR.
(C and D) WT iBMDMs were stimulated with Ec-LPS or Ft-LPS (1 mg/ml) for the times indicated. CD14 endocytosis (left), TLR4 endocytosis (middle), and TLR4/
MD-2 dimerization (right) were determined by flow cytometry (C) or myddosome was examined (D).
(E) Cells were treated with Ec-LPS and Bt-LPS species at the concentration of 1 ng/ml, 10 ng/ml, and 100 ng/ml for 4 hr; il1b and rsad2 expression wasmeasured
by qPCR.
(F) iBMDMswere stimulated with the LPS variants indicated (1 mg/ml). At the indicated times, CD14 endocytosis (left), TLR4 endocytosis (middle), and TLR4/MD-2
dimerization (right) were determined by flow cytometry.
Error bars represent mean SEM from triplicate readings in one experiment. **p < 0.01.
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R. sphaeroides and the pathogenic F. tularensis revealed two
mechanisms by which CD14-dependent effects on TLR4
signaling can be disrupted. Whereas R. sphaeroides LPS un-
couples CD14 endocytosis from TLR4 endocytosis, resulting in
a functional CD14 deficiency at the plasma membrane, the
other bacterial LPS variants evade detection by CD14 com-
pletely. Remarkably, our analysis ofB. thetaiotaomicron revealed
that this bacterium behaves similarly to pathogens, in that
B. thetaiotaomicron LPS evades CD14-dependent events. This
discovery is notable when considering that the LPS structure of
B. thetaiotaomicron is conserved across the genus Bacteroides,
which is one of the most dominant taxonomic groups in all mam-
mals. We therefore propose that the tendency to alter LPS to
evade CD14 probably represents an adaptation strategy that
transcends the concept of pathogenesis and includes any type
of persistent biological interaction between microbe and host.
Currently, the structural mechanism for how CD14 recognizes
LPS is elusive, because the published CD14 structures are in
their ligand-free conformations (Kelley et al., 2013; Kim et al.,
2005). Despite this gap in our knowledge, it is clear from our
observations that host-adapted pathogens and commensals
are able to avoid detection by CD14 via LPS modifications,
most notably dephosphorylation of their LPS. Interestingly,
LPS monophosphorylation not only is a mechanism of CD14
evasion, but also is a mechanism by which B. thetaiotaomicron
evades the killing activities of antimicrobial peptides (AMPs).
This finding reveals symmetry between the mechanisms of ac-
tion of the AMPs of the innate immune system and the receptors
that detect those microbes (PRRs).
Finally, the common activities of CD14 and MD-2 in transport-
ing ligands and receptors are reminiscent of the functions of taxi
motorcars in human society, which transport items and individ-
uals to pre-determined locations for a purpose. This similarity
prompts us to classify CD14 and MD-2 as transporters associ-
ated with the execution of inflammation, or ‘‘TAXI’’ proteins,
which transport various items throughout the cell for the purpose
of initiating an inflammatory signaling cascade. While it remains
to be determined whether other accessory proteins involved in
microbial ligand transport have the receptor-trafficking functions
of TAXI proteins, our studies provide a mandate for elucidating
these additional cell biological activities that control our interac-
tions with the microbial world.
EXPERIMENTAL PROCEDURES
Cell Lines, Transfection, and Retroviral Transduction
iBMDMs were cultured in complete DMEM (GIBCO) with 10% FBS and antibi-
otics. Primary BMDMs were cultured in complete RPMI with 15% FBS, 30%
L929 conditioned supernatant, and antibiotics. The J2 retrovirus was used
to immortalize primary BMDMs as described (Blasi et al., 1985). For generating
iBMDM stable lines, retroviruses expressing the indicated alleles were pro-
duced as described (Bonham et al., 2014). Transduced cells were subjected
to FACS to isolate stable lines at least 85% positive for the transgenes of inter-
est. Transient transfections were performed with the Fugene reagent accord-
ing to the manufacturer’s instructions.
Antibodies and Reagents
E. coli LPS was supplied by Enzo (ALX-581-012-L002), Pam3CSK4 from Inviv-
ogen (tlrl-pms), and Rs-LPS from Invivogen (tlrl-prslps). Anti-MyD88 (R&D;
AF3109), anti-IRAK2 (Prosci; 3595), anti-Actin (Sigma; A 5441), and anti-
CD14 (R&D; AF982) were supplied by the companies indicated. Anti-IRAK4920 Immunity 43, 909–922, November 17, 2015 ª2015 Elsevier Inc.antibody was a gift from Shizuo Akira. The following fluorophore-conjugated
antibodies were used: PE anti-TLR4 (Biolegend; clone Sa15-21; 145404),
APC anti-TLR4 (Biolegend; clone Sa15-21; 145406), PE/Cy7 anti-TLR4/
MD2 (Biolegend; clone MTS510; 117610), PE anti-CD48 (Biolegend; clone
HM48-1; 103406), FITC anti-CD14 (ebioscience; clone Sa2-8, 11-0141), APC
anti-CD14 (ebioscience; clone Sa-28, 17-0141), APC anti-hCD2 (Biolegend;
clone RPA-2.10; 300214), PE anti-CD4 (Biolegend; clone GK1.5;100408),
APC anti-HA (Miltenyi; 130-098-404), anti-E. coli (ab25823), anti-EEA1
(CST, 3288S), and donkey anti-Rabbit IgG (H+L) Alexa Fluor 568 conjugate
(Life Technologies, A10042). Cycloheximide (C1988), puromycin (P9620),
and Bay11-7085 (B5681) were purchased from Sigma.
cDNAs encoding full-length murine CD14, MD-2, and TLR4 were purchased
fromOpen Biosystems (GE Dharmacon). In particular, the NotI site in the CD14
DNA sequence was abolished by site-directed mutagenesis, which introduced
a neutral mutation in the nucleotides without altering amino acid composition.
For expression in mammalian cells, indicated cDNAs were cloned into
pcDNA3.1, pMSCV2.2-IRES-GFP (TLR4 and MD-2 alleles), or pMSCV2.2-
IRES-hCD2 (CD14 alleles).
qPCRprobeswere purchased fromLife Technologies as the following:Gapdh
(MM99999915_G1), Il1b (MM99999061_MH), Rsad2 (MM00491265_M1), and
Cd14 (Mm00438094_g1).
Myddosome Formation
Myddosome formation assays were performed as described (Bonham et al.,
2014).
mRNA Isolation and Real-Time qPCR
Total RNA was isolated from samples by means of the GeneJet RNA purifica-
tion kit (Thermo; K0732). Gene expression analyses were performed with the
Taqman one-step qPCR reagents (Life Technologies; 4392938) with indicated
probes according to the manufacturer’s instructions. Gene induction fold
changes were normalized to GAPDH, shown as mean and SD of three tech-
nical replicates. All qPCR graphs were representative data from at least three
independent experiments.
Flow Cytometry
iBMDMs, primary BMDMs (0.53 106) of the indicated genotypes were treated
as indicated at 37C. Cells were then washed with 1 ml cold PBS and stained
for appropriate antibodies on ice in the cold room for 20 to 30 min. 2%mouse
serum or rat serum were used as the blocking reagent to reduce non-specific
binding of the antibodies. The stained cells were then washed with 1 ml cold
PBS and resuspended in 200 ml PBS. Staining of the surface receptors was
analyzed with BD FACSCanto II. The mean fluorescence intensity (MFI) of
CD14, TLR4 from unstimulated or stimulated cells were recorded. The per-
centage of surface receptor staining at indicated time points, which is the ratio
of the MFI values measured from the stimulated cells to those measured from
the unstimulated cells, was plotted to reflect the efficiency of receptor endocy-
tosis. For measuring the extent of TLR4/MD-2 dimerization, the percentage of
TLR4/MD-2 dimer was calculated by 100% the percentage of TLR4/MD-2
monomer. The percentage of the TLR4/MD-2 monomer was determined by
the ratio of the MFI values (obtained from MTS510 antibody staining) of the
stimulated cells to those of the unstimulated cells. Flow cytometry graphs
shown in the results section were representative data from at least three inde-
pendent experiments.
E. coli Opsonization and Infection
Overnight E. coli culture was harvested by centrifugation and washed with
PBS twice. 1OD of bacteria were resuspended in 1ml PBS and the E. coli-spe-
cific antibody was added at a dilution factor of 1:50. The bacteria-antibody
mixture was incubated at 37C for 1 hr and unbound antibody was rinsed off
by 23 PBS wash. The opsonized bacteria were resuspended in warm PBS
and used to infect iBMDMs.
iBMDMs grown on coverslips (in a 24-well plate) were infected with E. coli at
an MOI of 5. After adding bacteria, the plate was centrifuged at 1,500 rpm for
5 min to synchronize infection. Bacterial uptake by iBMDMs were allowed for
5 min, and unbound bacteria were rinsed off by 33 washing with pre-warmed
PBS. Cells were then fixed with 4% paraformaldehyde and processed for
immunofluorescence staining.
Cells were fixed at room temperature for 30 min, permeabilized with 0.2%
Triton X-100 for 5 min at room temperature, and blocked with 2% goat serum
in PBS supplemented with 50 mM ammonium chloride. Primary and second-
ary antibody staining were performed according to product instructions. Cells
were imaged by confocal microscopy.
Anaerobic Culturing
Bacteroides thetaiotaomicron VPI-5482 (ATCC 29184) strains (Cullen et al.,
2015) were cultured anaerobically at 37C in liquid TYG medium (Holdeman
et al., 1977) in a flexible anaerobic chamber (Coy Laboratory Products) con-
taining 20% CO2, 10% H2, and 70% N2. Stationary-phase cultures were pel-
leted (8,000 3 g, 10 min), resuspended in phosphate-buffered saline at an
OD600 of 1.0 prior to use.
Statistical Analysis and Experimental Repeats
Means were compared by t tests (two groups) or one-way ANOVA (three or
more groups). Data are expressed and plotted as means ± SEM values.
All protein blots shownwere representative data from at least three indepen-
dent experiments. All FACS experiments were performed three times and one
representative result out of three is presented. All qPCR data were represen-
tative data from at least three independent experiments.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at http://dx.doi.org/10.1016/j.immuni.2015.10.008.
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